The independent source for health policy research, polling, and news.
51ĘÓƵ Health News’ coverage related to aging and improving care of older adults is supported in part by .
221-240 of 905 results
In a torrent of lawsuits, patients accuse Florida device maker Exactech of hiding knee and hip implant defects for years. The company denies the allegations.
Software sifts through millions of medical records to match patients with similar diagnoses and characteristics and then predicts what kind of care an individual will need and for how long. New federal rules will ensure human experts are part of the process.
In the wake of an investigation by 51ĘÓƵ Health News and Cox Media Group, the SSA acting commissioner said a special team will review “overpayment policies and procedures” and report directly back to her.
Lawmakers are faulting the Social Security Administration for issuing billions of dollars of payments that beneficiaries weren’t entitled to receive — and then demanding the money back — in the wake of an investigation by 51ĘÓƵ Health News and Cox Media Group.
As more seniors opt for Medicare Advantage, a few small insurers have begun offering plans that provide culturally targeted benefits for cohorts including Asian Americans, Latinos, and LGBTQ+ people. The approach, policy researchers say, has potential and perils.
51ĘÓƵ Health News gives readers a chance to comment on a recent batch of stories.
“People want covid-19 to be in the rearview mirror,” one nursing home official says. Faced with a slow rollout of the updated covid vaccines, and without state mandates for workers to get vaccinated, most skilled nursing facilities are relying on persuasion to boost vaccination rates among staff and residents.
Americans think losing their eyesight would be one of the worst possible health outcomes, yet millions lack a fundamental understanding of eye health.
Beneficiaries in five states described what happened when they received letters calling on them to return overpayments that can reach tens of thousands of dollars or more.
The Biden administration says a recently proposed minimum staffing standard would help ensure quality care, but nursing home leaders predict many rural facilities would struggle to meet it.
As covid-19 hospitalizations tick upward with fall approaching, the CDC says it’s time for new boosters — and not only for those at highest risk of serious disease. Here are seven things you need to know.
The proposal would require major hiring at the most sparsely staffed homes. But the proposal is already badly received by the nursing home industry, which claims it can’t boost wages enough to attract workers.
Research commissioned by the Centers for Medicare & Medicaid Services analyzed only staffing levels below what experts have previously called ideal. Patient advocates have been pushing for more staff to improve care.
The federal government is proposing having Medicare pay professionals to train family caregivers how to perform tasks like bathing and dressing their loved ones, and properly use medical equipment.
Clinics serving Alzheimer’s patients are working out the details of who will get treated with the new drug Leqembi. It won’t be for everyone with memory-loss symptoms.
Each year, Medicare punishes hospitals that have high rates of readmissions and high rates of infections and patient injuries. Check out which hospitals have been penalized.
The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer’s, experts say.
Although nearly 40% of Americans 60 and older are obese, Medicare doesn’t cover weight loss medications. Meanwhile, studies haven’t thoroughly examined new drugs’ impact on older adults.
Researchers have found that while obesity at any age risks harming health, a few extra pounds in later life isn’t cause for concern.
Black patients and other minorities tend to be diagnosed at later stages of the disease, which would exclude them from use of Leqembi. Few Black people were included in the main trial of the drug.
© 2026 51ĘÓƵ